62 related articles for article (PubMed ID: 8108132)
1. A versatile expression vector for the in vitro study of protein-protein interactions: characterization of E47 mutant proteins.
Hainzl T; Boehm T
Oncogene; 1994 Mar; 9(3):885-91. PubMed ID: 8108132
[TBL] [Abstract][Full Text] [Related]
2. Identification of interaction partners for the basic-helix-loop-helix protein E47.
Dear TN; Hainzl T; Follo M; Nehls M; Wilmore H; Matena K; Boehm T
Oncogene; 1997 Feb; 14(8):891-8. PubMed ID: 9050988
[TBL] [Abstract][Full Text] [Related]
3. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
4. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
Maira SM; Wurtz JM; Wasylyk B
EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
[TBL] [Abstract][Full Text] [Related]
5. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.
Lu J; Sloan SR
Biochem Biophys Res Commun; 2002 Feb; 290(5):1521-8. PubMed ID: 11820794
[TBL] [Abstract][Full Text] [Related]
6. Nuclear redirection of a cytoplasmic helix-loop-helix protein via heterodimerization with a nuclear localizing partner.
Goldfarb AN; Lewandowska K
Exp Cell Res; 1994 Oct; 214(2):481-5. PubMed ID: 7925642
[TBL] [Abstract][Full Text] [Related]
7. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain.
Law SF; Zhang YZ; Fashena SJ; Toby G; Estojak J; Golemis EA
Exp Cell Res; 1999 Oct; 252(1):224-35. PubMed ID: 10502414
[TBL] [Abstract][Full Text] [Related]
8. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
9. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
10. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
11. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
12. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
Suzuki M; Okuyama S; Okamoto S; Shirasuna K; Nakajima T; Hachiya T; Nojima H; Sekiya S; Oda K
Oncogene; 1998 Aug; 17(7):853-65. PubMed ID: 9780002
[TBL] [Abstract][Full Text] [Related]
13. DNA binding properties of basic helix-loop-helix fusion proteins of Tal and E47.
Ghosh I; Bishop P; Chmielewski J
J Pept Res; 2001 May; 57(5):354-60. PubMed ID: 11350595
[TBL] [Abstract][Full Text] [Related]
14. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
15. Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression.
Terai S; Aoki H; Ashida K; Thorgeirsson SS
Hepatology; 2000 Aug; 32(2):357-66. PubMed ID: 10915743
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
Hsu HL; Wadman I; Tsan JT; Baer R
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
[TBL] [Abstract][Full Text] [Related]
17. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
Hsu HL; Cheng JT; Chen Q; Baer R
Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
[TBL] [Abstract][Full Text] [Related]
18. Heteronuclear (1H, 13C, 15N) NMR assignments and secondary structure of the basic region-helix-loop-helix domain of E47.
Fairman R; Beran-Steed RK; Handel TM
Protein Sci; 1997 Jan; 6(1):175-84. PubMed ID: 9007990
[TBL] [Abstract][Full Text] [Related]
19. Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.
Voronova A; Baltimore D
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4722-6. PubMed ID: 2112746
[TBL] [Abstract][Full Text] [Related]
20. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
Miyamoto A; Cui X; Naumovski L; Cleary ML
Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
